A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United States

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 11-12, 1999, Pages 1067-1076

  Nauck, Matthias ^a   Graziani, Maria Stella ^b   Jarausch, Jochen ^c   Bruton, Deborah ^c   Cobbaert, Christa ^h   Cole, Thomas G ^d   Colella, Francesca ^b   Lefevre, Fabrice ^e   Gillery, Philippe ^e   Haas, Brigitte ^a   Law, Terence ^f   König, Michael ^c   Macke, Michael ^d   März, Winfried ^a   Meier, Claudine ^g   Riesen, Walter ^g   Van Vliet, Martin ^h   Wieland, Heinrich ^a   Rifai, Nader ^f  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Laboratorio Chimica Clinica   (Italy)

^c Roche Diagnostics Corporation   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SERVICE DE DERMATOLOGIE   (France)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g Inst Klin Chem Hamatologie K   (Switzerland)

^h NONE

Author keywords

High density lipoprotein (HDL); Lipoprotein cholesterol; Low density lipoprotein (LDL)

Indexed keywords

APOLIPOPROTEIN A; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RHEUMATOID FACTOR; TRIACYLGLYCEROL;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; ASSAY; CHOLESTEROL BLOOD LEVEL; CLINICAL CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ASSAY; HUMAN; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PARAPROTEINEMIA; PRECIPITATION; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

EID: 18544398792     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.156     Document Type: Article

References (41)

1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994; 308:367-72.
2. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988; 8:737-41.
3. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994; 89:1330-445.
4. International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis 1992; 2:113-56.
5. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18:499-509.
6. Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high density lipoprotein cholesterol quantification. Clin Chem 1979; 25:596-604.
7. Demacker PNM, Vos-Janssen HE, Hijmans AGM, van't Laar A, Janssen AP. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods with enzymatic cholesterol analysis. Clin Chem 1980; 26:1780-6.
8. Sugiuchi H, Yoshinori U, Okabe H, Irie T, Uekama K, Kayahara N, et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycolmodified enzymes and a-cyclodextrin. Clin Chem 1995; 41:717-23.
9. Nauck M, März W, Haas B, Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem 1996; 42:424-9.
10. Harris N, Galpachian V, Rifai N. Three routine methods for measuring high-density lipoprotein cholesterol compared with the reference method. Clin Chem 1996; 42:738-43.
11. 2+ method. Clin Chem 1997; 43:816-23.
12. Huang YC, Kao JT, Tsai KS. Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol. Clin Chem 1997; 43:1048-55.
13. Nauck M, März W, Wieland H. New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol. Clin Chem 1998; 44:1443-51.
14. Harris N, Neufeld EJ, Newburger JW, Ticho B, Baker A, Ginsburg G, et al. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. Clin Chem. 1996; 42:1182-8.
15. Manual of laboratory operation. Lipid Research Clinics Program. DHEW No. (NIH) 75-628. Bethesda, MD: National Heart and Lung Institute, 1974:1-74.
16. Wanner C, Hörl WH, Luley C, Wieland H. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 1991; 39:754-9.
17. 3 in a random population of healthy French males and females. Evaluation by a two-step precipitation procedure. Clin Chim Acta 1990; 189:111-22.
18. Lippi U, Graziani MS, Manzato F, Schinella M. Procedure for effective separation of high-density lipoproteins in normal serum and in hypertriglyceridemic samples. Clin Biochem 1987; 20:313-5.
19. Wiebe DA, Warnick GR. Measurement of high-density lipoprotein cholesterol. In: Rifai, N, Warnick GR, eds. Handbook of lipoprotein testing. Washington, DC: AACC Press, 1997:127-44.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma. J Clin Invest 1955; 34:1345-53.
21. Click MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986; 32:470-5.
22. Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample size. Part II. J Clin Chem Clin Biochem 1984; 22:431-45.
23. NCCLS Tentative Guidline EP5-T. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, June 1984.
24. Carey RN, Garber CC. Evaluation of methods. In: Kaplan LA, Pesce AJ, eds. Clinical chemistry: theory, analysis and correlation, 3rd ed. St. Louis: CV Mosby Co., 1996:402-23.
25. Westgard JO, Carey RN, Wold S. Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 1974; 20:825-33.
26. Warnick GR, Wood PD for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program Recommendations for Measurement of high-density lipoprotein cholesterol: executive summary. Clin Chem 1995; 41:1427-33.
27. 2 precipitation and a quantitative lipoprotein electrophoresis assay. Clin Chim Acta 1986; 160:1-18.
28. Demacker PMN, Hessels M, Toenhake-Dijkstra H, Baadenhuijsen H. Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low-to-reagent ratio. Clin Chem 1997; 43:663-8.
29. Nauck M, März W, Jarausch J, Cobbaert C, Sägers A, Bernard D, et al. Multicenter evaluation of a homogeneous assay for HDL cholesterol without sample pre-treatment. Clin Chem 1997; 43:1622-9.
30. Cobbaert C, Zwang L, Ceriotti F, Modenese A, Cremer P, Herrmann W, et al. Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay. Clin Chem 1998; 44:779-89.
31. Rifai N, Cole TG, Ianotti E, Law T, Macke M, Miller R, et al. Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay. Clin Chem 1998; 44:1452-8.
32. 2 and a lyophilized homogeneous assay. Clin Chem Lab Med 1999; 37:537-43.
33. Halloran P, Roetering H, Pisani T, van den Berg B, Cobbaert, C. Reference Standardization and analytical performance of a liquid HDL-cholesterol method compared to a chemical precipitation method. Arch Pathol Lab Med 1999; 123:317-26.
34. de Keijzer MH, Elbers D, Baadenhuijsen H, Demacker PNM. Evaluation of five different high-density lipoprotein cholesterol assays: the most precise are not the most accurate. Ann of Clin Biochem 1999; 36:168-75.
35. Chang L, Clifton P, Barter P, Mackinnon M. High density lipoprotein subpopulations in chronic liver disease. Hepatology 1986; 6:46-9.
36. Savory DJ, Pearce CJ. Paraprotein interference causing pseudohyperphosphatemia: evaluation of an improved methodology. Ann Clin Biochem 1995; 32:498-501.
37. 1 antitrypsin) in patients with rheumatoid arthritis: interference by rheumatoid factor. Ann Rheum Dis 1990; 49:18-21.
38. Chambers RE, Whicher WT, Perry DE, Milford-Word A, White PA, Fifield R. Overestimation of immunoglobulins in the presence of rheumatoid factor by kinetic immunonephelometry and rapid immunoturbidimetry. Ann Clin Biochem 1987; 24:520-4.
39. Gogstad GO, Dale S, Brosstad F, Brandsnes O, Holtlund J,Mork E, et al. Assay of D-dimer based on immunofiltration and staining with gold colloids. Clin Chem 1993; 39:2070-6.
40. Cloey T, Bachorik PS, Becker D, Finney C, Lowry D, Sigmund W. Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA 1992; 267:234-5.
41. Behesti I, Wessels LM, Eckfeldt JH. EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods. Clin Chem 1994; 40:2088-92.